📣 New publication: Andes hantavirus outbreak on a cruise ship - an ESCMID Emerging Infections Subcommittee (EIS) rapid assessment
https://t.co/h7TpoZQ5vT
In this latest @ESCMID clinical guideline, a panel of 16 multidisciplinary experts provide recommendations for how to evaluate and manage patients with reported antibiotic allergies.
https://t.co/Q9CRcuVMwZ
📣 New publication: First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib: https://t.co/8YhcdPuWDA
#hantavirus
Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo and Uganda: rapid assessment from the ESCMID Emerging Infections Subcommittee
@CMIJournal@ESCMID https://t.co/D7HVdj6omX
In this study, Pinot et al assessed whether chest X-ray and/or C-reactive protein testing could influence antibiotic initiation among French general practitioners managing outpatients with suspected community-acquired pneumonia.
Read the full article: https://t.co/mPp91iGsc6
✏️Clinical Microbiology and Infection (CMI) is looking for an editor in virology to join their editorial board.
💡Learn more about the qualifications and expectations of the role, and how to apply in the editorial note: https://t.co/AKWQ2BCMMs
@cmijournal
Paper 🚨: in this Narrative Review we describe the challenges and opportunity of a microbiome research facility, based on our experiences at @LUMC_Leiden with Center for Microbiome Analyses and Therapeutics (CMAT) #ESGHAMI@ESCMID@CMIJournal@EdKuijper2 https://t.co/o3fyqjHlCA
How to safely discontinue antifungal treatment in invasive pulmonary aspergillosis? – Clinical considerations in haematology
@CMIJournal
https://t.co/y9vpDFaPQU
https://t.co/szbJt5Huzn
Review of our experiences in the past 6 years to establish a Microbiota Center in an academic setting with many stakeholders and an excellent research group of George Zeller. @SmitsLab@NicolasBenech2@CMIJournal@EurFmt